Harvard

Both HbA1c and continuous glucose monitoring metrics have limitations, and providers should not rely on a single metric for managing a patient’s diabetes, according to two speakers.

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone reduced risk for CV death and worsening HF by 16% compared with placebo, researchers reported at the European Society of Cardiology Congress.

In an analysis of deaths of patients with obesity but not diabetes from the SELECT trial, those assigned semaglutide 2.4 mg had reduced risk for death from COVID-19 compared with those assigned placebo.

Older adults with diabetes who spend less time within their individualized HbA1c target range have a higher risk for developing Alzheimer’s disease and dementias, according to findings published in JAMA Network Open.

Fixed-duration acalabrutinib plus venetoclax, with or without obinutuzumab, improved survival compared with standard chemoimmunotherapy for certain adults with leukemia, according to a topline data announcement.

The American Society for Radiation Oncology has issued an updated clinical guideline that outlines best practices for addressing symptomatic bone metastases and improving quality of life for these patients.

It’s only the beginning.

Physician coaching by professionally trained peers effectively decreased physician burnout and interpersonal disconnectedness, according to study results published in JAMA Network Open.

Adults with a sleep duration that varies by a mean of more than 1 hour each night may have an increased risk for developing diabetes, according to a study published in Diabetes Care.

Men are more than twice as likely than women to develop IgG4-related disease, and demonstrate “striking” sex-dependent organ distribution and B-cell response, according to data published in The Lancet Rheumatology.